Operating
Other Working Capital
Bristol-Myers Squibb Other Working Capital increased by 253.2% to $1.64B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 54.5%, from $1.06B to $1.64B. Over 2 years (FY 2021 to FY 2025), Other Working Capital shows a downward trend with a 35.4% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryEfficiency
SignalContext dependent
VolatilityModerate
First reportedQ1 2015
Last reportedQ1 2026
How to read this metric
Positive changes suggest a source of cash from optimizing minor balance sheet items, while negative changes indicate cash is being tied up in these categories.
Detailed definition
The aggregate net change in miscellaneous operating assets and liabilities not specifically categorized in major line it...
Peer comparison
This is often used to reconcile net income to cash flow and varies based on a company's specific accounting classifications for 'other' items.
Metric ID:
change_in_other_working_capitalHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$442.00M | -$1.07B | $627.00M | $1.07B | $191.00M | $46.00M | $1.06B | -$173.00M | $59.00M | $608.00M | -$340.00M | -$167.00M | -$725.00M | $1.06B | -$222.00M | -$240.00M | -$1.07B | $1.64B |
| QoQ Change | — | -141.0% | +158.9% | +71.1% | -82.2% | -75.9% | >999% | -116.3% | +134.1% | +930.5% | -155.9% | +50.9% | -334.1% | +246.1% | -121.0% | -8.1% | -345.0% | +253.2% |
| YoY Change | — | — | — | — | +143.2% | +104.3% | -0.8% | -190.6% | +28.3% | -42.9% | -96.5% | -383.1% | — | +74.2% | +34.7% | -43.7% | -47.3% | +54.5% |
Range-$1.07B – $1.64B
CAGR+36.1%
Avg YoY Growth-28.1%
Median YoY Growth-0.8%
Other Working Capital at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's other working capital?
- Bristol-Myers Squibb (BMY) reported other working capital of $1.64B in Q1 2026.
- How has Bristol-Myers Squibb's other working capital changed year-over-year?
- Bristol-Myers Squibb's other working capital increased by 54.5% year-over-year, from $1.06B to $1.64B.
- What is the long-term trend for Bristol-Myers Squibb's other working capital?
- Over 2 years (2021 to 2025), Bristol-Myers Squibb's other working capital has grown at a 35.4% compound annual growth rate (CAGR), from $257.00M to -$471.00M.
- What does other working capital mean?
- The cash impact from changes in various smaller business assets and obligations used in daily operations.